# Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes

> **NCT01453751** · NA · WITHDRAWN · sponsor: **Ageless Regenerative Institute**

## Conditions studied

- Diabetes Mellitus Type II

## Interventions

- **PROCEDURE:** Harvesting and Implantation of Adipose-Derived Stromal Vascular Fraction (AD-SVF)

## Key facts

- **NCT ID:** NCT01453751
- **Lead sponsor:** Ageless Regenerative Institute
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-03
- **Primary completion:** 2017-11
- **Final completion:** 2017-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** company dissolved
- **Last updated:** 2017-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01453751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01453751, "Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01453751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*